Navigation Links
Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
Date:5/22/2013

New York, NY (PRWEB) May 22, 2013

Patients with type 1 diabetes (T1D) who are treated with insulin pump therapy have better glycemic control as measured by significantly lower HbA1C levels than patients with T1D who treat their condition with insulin injections, according to new findings from the National Health and Wellness Survey (NHWS), conducted by Kantar Health. The research was presented at the 18th Annual International Meeting for ISPOR (International Society for Pharmacoeconomics and Outcomes Research) in New Orleans.

“Patients with type 1 diabetes who have better access to healthcare are more likely to use insulin pump therapy, but even after adjusting for these differences in multivariable modeling we found that insulin pump therapy is a significant predictor of patients’ clinical outcomes,” said Shaloo Gupta, MS, senior research analyst with Kantar Health. “In particular, patients with type 1 diabetes using insulin pump therapy are more likely to control their diabetes than those who are taking insulin injections.”

Patients with T1D who use insulin pump therapy reported significantly lower levels of HbA1C than patients who take multiple daily insulin injections. Nearly 40 percent of those using insulin pump therapy reported HbA1C levels of less than 7 percent, which is considered to be controlled, versus 24 percent of patients using insulin injections.

“Having consistently high HbA1C levels can increase the risk of developing microvascular and macrovascular complications, such as cardiovascular disease, kidney failure, blindness and neuropathy, among those with diabetes,” Gupta said. “Our research suggests that insulin pump therapy is associated with lower blood sugar levels and therefore may lower the risks of these serious complications.”

Visit Kantar Health’s website to download the full poster, “The Effect of Insulin Pump Therapy on HbA1C among Those with Type 1 Diabetes.”

About the National Health and Wellness Survey (NHWS)
The study’s results were drawn from the 2009, 2010, 2011 and 2012 U.S. NHWS, a nationally representative, self-administered survey conducted annually. Topics covered include the health status, attitudes, behaviors and outcomes among adults 18 or older.

Kantar Health conducts the NHWS in the U.S., Europe, Asia and Latin America. The survey is the largest self-reported dataset in the healthcare industry.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech, and medical device and diagnostic companies. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from pre-clinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10743580.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tiny RNA molecule may have role in polycystic ovary syndrome, insulin resistance
2. Case Western Reserve receives Helmsley Trust grant to develop new glucose-sensitive insulin
3. Taking insulin for type 2 diabetes could expose patients to greater risk of health complications
4. Binge drinking increases risk of Type 2 diabetes by causing insulin resistance
5. Stop diabetes with insulin tablets
6. JDRF announces winners of first phase of Agnes Varis Glucose-Responsive Insulin Challenge
7. Single gene cause of insulin sensitivity may offer insight for treating diabetes
8. Scientists ID Gene for Insulin Sensitivity
9. New marker for identifying precursors to insulin-producing cells in pancreas
10. Link between brain insulin resistance, neuronal stress in worsening Alzheimers disease
11. No Cancer Risk From Long-Acting Insulin: Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... May 05, 2016 , ... ... community enrichment program serving families of greater Dubuque, IA. The current campaign fundraises ... and honorably discharged veterans. Donations to Veteran’s Freedom Center may now be made ...
(Date:5/5/2016)... ... May 05, 2016 , ... A local study examining ... than 40 percent of participating fifth-grade students already have or are at risk ... Clinical Research in the Division of Pulmonary, Allergy and Critical Care Medicine at ...
(Date:5/5/2016)... ... May 05, 2016 , ... TIME for Kids and ... today announced a new partnership to reach nearly 1 million children with important water ... instant and is the leading cause of accidental death in children one to 6 ...
(Date:5/5/2016)... , ... May 05, 2016 , ... ... Drago presented a talk highlighting the organization’s successful Care Transitions program ... , The talk was titled “Minimizing Costs in the Post-Acute Environment Through Effective ...
(Date:5/5/2016)... ... May 05, 2016 , ... The 2016 Nike Soccer ... Pittman, along with his university coaching staff. Together they bring their winning Vandals coaching ... run for youth players ages 5-13, and high school players. Session dates are as ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
(Date:5/3/2016)... May 4, 2016 Research and ... Cancer Stem Cell Therapy Market Outlook 2020" report ... ) , ,Recombinant technology has improved significantly in ... to be developed in coming years. Many cancer drugs ... stem cell therapies are also expected to be developed ...
Breaking Medicine Technology: